DEVELOPMENT AND COMMERCIALIZATION FUNDING AGREEMENTDevelopment and Commercialization Funding Agreement • August 10th, 2020 • Reata Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Development and Commercialization Funding Agreement (“Agreement”), made effective as of June 10, 2020 (the “Effective Date”), is by and between Reata Pharmaceuticals Inc., a Delaware corporation (“Reata”), and BXLS V – River L.P. (together with its successors and assigns, “BXLS”), a limited partnership organized and existing under the laws of Delaware (each, a “Party” and collectively, the “Parties”).
COMMON STOCK PURCHASE AGREEMENT BY AND BETWEEN REATA PHARMACEUTICALS, INC. ANDCommon Stock Purchase Agreement • August 10th, 2020 • Reata Pharmaceuticals Inc • Pharmaceutical preparations
This COMMON STOCK PURCHASE AGREEMENT, dated as of June 10, 2020 (this “Agreement”), is entered into by and between REATA PHARMACEUTICALS, INC., a Delaware corporation (“Reata”), BXLS V – River L.P., (“BXLS V”), a limited partnership organized and existing under the laws of Delaware, and BXLS Family Investment Partnership (CYM) V – ESC L.P., a limited partnership organized and existing under the laws of Delaware (together with BXLS V, collectively, “BXLS” and each, a “BXLS Entity”) (each, a “Party” and collectively, the “Parties”).
FIRST AMENDMENT TO LEASE AGREEMENTLease Agreement • August 10th, 2020 • Reata Pharmaceuticals Inc • Pharmaceutical preparations
THIS FIRST AMENDMENT TO LEASE AGREEMENT (this “Amendment”) is made and entered into as of this 27 day of May, 2020, by and between TC LEGACY PHASE I VENTURE, LLC, a Delaware limited liability company (“Landlord”), and REATA PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”).
